Growth Metrics

Microbot Medical (MBOT) Net Margin (2016)

Historic Net Margin for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to 5775.44%.

  • Microbot Medical's Net Margin rose 214797600.0% to 5775.44% in Q3 2016 from the same period last year, while for Dec 2016 it was 24179.28%, marking a year-over-year increase of 75891000.0%. This contributed to the annual value of 31842.04% for FY2015, which is N/A changed from last year.
  • Microbot Medical's Net Margin amounted to 5775.44% in Q3 2016, which was up 214797600.0% from 30295.83% recorded in Q2 2016.
  • In the past 5 years, Microbot Medical's Net Margin ranged from a high of 12.57% in Q4 2014 and a low of 43550.75% during Q1 2015
  • Moreover, its 5-year median value for Net Margin was 1926.61% (2012), whereas its average is 11583.22%.
  • In the last 5 years, Microbot Medical's Net Margin tumbled by -433090900bps in 2015 and then soared by 214797600bps in 2016.
  • Quarter analysis of 5 years shows Microbot Medical's Net Margin stood at 2919.28% in 2012, then skyrocketed by 91bps to 255.56% in 2013, then skyrocketed by 95bps to 12.57% in 2014, then crashed by -234860bps to 29536.33% in 2015, then soared by 80bps to 5775.44% in 2016.
  • Its Net Margin was 5775.44% in Q3 2016, compared to 30295.83% in Q2 2016 and 42469.06% in Q1 2016.